IRCT20171122037584N1招募中未知
Investigation the effect of Silymarin on reducing lead blood concentration and oxidative stress biomarkers in opioid addicts.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •18-60 years old
- •blood lead level>10mcg/dl
- •opium abuser
排除标准
- •Age under 18 years
- •Get other types of other antioxidants
- •Gastrointestinal diseases, especially absorption disorders, which can affect the effective absorption of the drug
- •History of heart, kidney, and liver disease
研究者
相似试验
已完成
2 期
The effect of salimarin in patients with multiple sclerosisMultiple sclerosisIRCT20150628022956N7Research Council of Hamedan University of Medical Sciences48
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
尚未招募
3 期
Effect of silymarin in the treatment of patients with depressioIRCT20160804029191N4Mashhad University of Medical Sciences80
进行中（未招募）
1 期
A dose-finding clinical study investigating the effects of different doses of silymarin compared to placebo on elevated liver enzymes due to drug-induced liver enzyme elevation.EUCTR2020-004645-36-DEFraunhofer Gesellschaft for its Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)156
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64